Pasithea Therapeutics KTTAW
NASDAQ KTTAW
$0.00 0.00 (-36.36%)
As of: Sep 9, 2026 · 3:56 PM EDT

Pasithea Therapeutics Corp. (KTTAW) Acquisitions (2022)

Pasithea Therapeutics' (KTTAW) quarterly Acquisitions came in at $2.2 million in Q4 2022, up 10881.77% quarter-over-quarter from $20481.0 in Q3 2022.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Pasithea Therapeutics Corp. (KTTAW) Acquisitions (2022) Analysis & Trends

Pasithea Therapeutics has disclosed Acquisitions across 1 years of filings, most recently posting $2.2 million for Q4 2022.

Peer Set

Peer Comparison

All peers
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 2.25 Mn
Sep 30, 2022 20,481.00